The Proteomics of Precision – with Jennifer Van Eyk - Takeaways - MDSpire

The Proteomics of Precision – with Jennifer Van Eyk

Ahead of ISC2026 in Prague, Jennifer Van Eyk explains how scalable LC-MS workflows and single-cell proteomics are helping reveal the biological differences that could make precision medicine a clinical reality

  • By

  • James Strachan

  • Frank van Geel

  • June 17, 2026

  • 5 min

Share

  • 1

    Jennifer Van Eyk focuses on developing scalable LC-MS methods for individualized healthcare, particularly in women's heart health.

  • 2

    Her team has created automated workflows for transitioning from discovery proteomics to targeted assays suitable for large cohorts.

  • 3

    Single-cell proteomics has become feasible due to advancements in analytical chemistry, enabling quantitative data from individual cells.

  • 4

    Accurate quantification of proteomic heterogeneity is essential for precision medicine, allowing tailored diagnostics and therapies.

  • 5

    Van Eyk's upcoming ISC 2026 presentation will highlight workflows addressing proteome heterogeneity in the heart at the single-cell level.

Original Source(s)

The Proteomics of Precision – with Jennifer Van Eyk

  • by James Strachan, Frank van Geel

  • June 17, 2026

Related Content

3 Medical Routines That Older People May Not Need

“The treatment may be more burdensome than the condition itself."

California considers seal of approval for foods that are not ultra-processed

Echocardiography and Structural Heart Symposium, 43rd Annual

As valvular heart disease and structural heart treatments become increasingly integral within cardiology, our symposium focuses on building the fundamental tools of echocardiography.

  • March 20, 2026

  • 2 min